85 related articles for article (PubMed ID: 2959964)
21. Thromboxane A2 in cardiovascular and renal disorders: is there a defined role for thromboxane receptor antagonists or thromboxane synthase inhibitors?
Smith EF
Eicosanoids; 1989; 2(4):199-212. PubMed ID: 2534279
[TBL] [Abstract][Full Text] [Related]
22. Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablation.
Brooks DP; Contino LC; Trizna W; Edwards RM; Ohlstein EH; Solleveld HA
J Pharmacol Exp Ther; 1990 Apr; 253(1):119-23. PubMed ID: 2139468
[TBL] [Abstract][Full Text] [Related]
23. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.
Fiddler GI; Lumley P
Circulation; 1990 Jan; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitor of thromboxane A2 synthesis as anticoagulant in hemodialysis].
Iida N
Nihon Rinsho; 1991 Dec; 49 Suppl():746-52. PubMed ID: 1839689
[No Abstract] [Full Text] [Related]
25. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
Yoo J; Schlondorff D; Neugarten J
J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2 alpha-induced sudden death in guinea-pigs and rats.
Shirakura S; Karasawa A; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1242-5. PubMed ID: 1815523
[TBL] [Abstract][Full Text] [Related]
27. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
28. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
29. Thromboxane A2 and development of genetic hypertension in the Lyon rat strain.
Geoffroy J; Benzoni D; Vincent M; Sassard J
Hypertension; 1990 Dec; 16(6):655-61. PubMed ID: 2147173
[TBL] [Abstract][Full Text] [Related]
30. Tumour cell proliferation by thromboxane A2: a receptor-mediated event.
Nigam S; Zakrzewicz A
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():925-8. PubMed ID: 1705088
[No Abstract] [Full Text] [Related]
31. Biosynthesis and pharmacological modulation of thromboxane in humans.
Patrono C
Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
[TBL] [Abstract][Full Text] [Related]
32. Dibenz[b,e]oxepin derivatives: novel antiallergic agents possessing thromboxane A2 and histamine H1 dual antagonizing activity. 1.
Ohshima E; Takami H; Harakawa H; Sato H; Obase H; Miki I; Ishii A; Ishii H; Sasaki Y; Ohmori K
J Med Chem; 1993 Feb; 36(3):417-20. PubMed ID: 8093908
[No Abstract] [Full Text] [Related]
33. [Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat].
Nakayama D; Ikeda T
Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):79-84. PubMed ID: 3386014
[No Abstract] [Full Text] [Related]
34. Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels.
García-Redondo AB; Briones AM; Beltrán AE; Alonso MJ; Simonsen U; Salaices M
J Pharmacol Exp Ther; 2009 Jan; 328(1):19-27. PubMed ID: 18818375
[TBL] [Abstract][Full Text] [Related]
35. [Thromboxane antagonism in thrombocytes--pathophysiology, pharmacology and possible clinical significance].
Schrör K
Wien Klin Wochenschr; 1991; 103(18):543-53. PubMed ID: 1836294
[TBL] [Abstract][Full Text] [Related]
36. Determination of a new thromboxane A2 receptor blocker in biological fluids by capillary gas chromatography with electron-capture detection.
Uebis V
J Chromatogr; 1987 Aug; 419():345-50. PubMed ID: 2959674
[No Abstract] [Full Text] [Related]
37. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
[No Abstract] [Full Text] [Related]
38. The effects of thromboxane receptor antagonists on oestrogen-induced uterotrophic responses in the spontaneously hypertensive rat.
Kerr MB; Marshall K; Senior J
Br J Pharmacol; 1991 Jun; 103(2):1363-6. PubMed ID: 1832065
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
Aoki N; Lefer AM
Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
Aoki N; Johnson G; Siegfried MR; Lefer AM
Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
